You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動丨開拓藥業高開近11%,連續第二日大漲
繼昨日收漲超11%後,開拓藥業-B(9939.HK)今早再度高開近11%,報1.86港元,股價創2024年2月以來新高。開拓藥業5月份宣佈,其外用雄激素受體(AR)拮抗劑KX-826與米諾地爾聯合治療中國成年男性脫髮臨牀觀察試驗,已達到主要研究終點。與此同時,公司具有美白祛斑功能的功效性化妝品原料KT -939正式啓動全球銷售業務,並已成功完成首份原料銷售,是唯一入選2025紐約化妝品原料展(NYSCC)Inspiration Hive展區的“中國成分”。在醫藥與消費結合的新趨勢下,開拓藥業正在通過“外用創新藥研發+化妝品產品業務+化妝品原料業務”三駕馬車驅動轉型。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account